Riber half-year revenues down 22%
French MBE company Riber has reported its results for the first half of 2025 with revenues of €10.7m, down 22 percent compared with the same period in 2024.
Riber says that it is trading in a complex international environment, but has demonstrated the resilience of its business model and the appeal of its technology offering. The company also reiterated that its business activity is subject to seasonal trends, with revenue structurally lower in the first half of the year.
Systems revenues totalled €7.8m, down 17 percent, reflecting the delivery schedule agreed with customers for systems on order in 2025. This corresponds to the delivery of three machines, including two production systems, compared with three production systems in the same period last year.
Revenues for services and accessories came to €3.0m, down 31 percent, primarily due to a temporary decline in research-related orders, particularly in the United States, against a backdrop of tighter budgets in universities and research laboratories.
The geographical breakdown of half-year revenues was as follows: Europe (15 percent), Asia (70 percent) and North America (13 percent).
Despite ongoing geopolitical tensions and regulatory constraints, Riber says it maintained strong commercial momentum during the first half of 2025.
The company secured five new system orders, including the first order for ROSIE, its new 300 mm silicon photonics platform, which recently entered its industrialization phase.
As of June 30, 2025, the systems order book stood at €22.5m, down 25 percent from the high base in the first half of 2024. It includes nine systems, of which six are production machines. This change is mainly due to the denial of two export licenses, representing €4m in unbooked orders, and longer license approval timelines, which delayed the booking of already-identified orders.
The services and accessories order book is down 11 percent to €5.2m.
Outlook
Riber anticipates an improvement in order intake during the second half of the year, driven by major global investment programs in the semiconductor industry.
The company also expects to benefit from the ramp-up of its ROSIE platform, a breakthrough technology in silicon-based integrated photonics. Following the signing of a strategic partnership with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) and the first unit sale, Riber aims to leverage growing interest from both research institutions and industrial players for solutions compatible with silicon fabrication lines.
While short-term momentum in research-related services and accessories remains uncertain, the systems business is expected to remain broadly stable in 2025. These elements do not undermine the company’s strong fundamentals, it says.
Given the current order book for delivery this year and the upcoming business opportunities, Riber expects to generate full-year revenue of over €40m in 2025.
